These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 3012808

  • 41. Clinical evaluation of sulbactam plus ampicillin in the treatment of general pediatric infections.
    Bassetti D, Solbiati M, Ravelli A, Martini A, Viola S, Burgio RG.
    APMIS Suppl; 1989; 5():41-4. PubMed ID: 2660870
    [Abstract] [Full Text] [Related]

  • 42. Comparative evaluation of clindamycin versus clindamycin plus tobramycin in the treatment of acute pelvic inflammatory disease.
    Gall SA, Constantine L.
    Obstet Gynecol; 1990 Feb; 75(2):282-6. PubMed ID: 2405323
    [Abstract] [Full Text] [Related]

  • 43. Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections.
    Solomkin JS, Cocchetto DM.
    Clin Ther; 1986 Feb; 9(1):123-34. PubMed ID: 3545476
    [Abstract] [Full Text] [Related]

  • 44. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
    Betrosian AP, Douzinas EE.
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Sulbactam/ampicillin combination in the treatment of acute and chronic lower respiratory infections.
    Bisetti A, Grassi L, Scacciacillani E, Putti P.
    J Int Med Res; 1991 Sep; 19 Suppl 1():36A-43A. PubMed ID: 2060692
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. The parenteral kinetics of ampicillin/sulbactam in man.
    Foulds G, Knirsch AK, Stankewich JP, Weidler DR.
    Int J Clin Pharmacol Res; 1985 Sep; 5(2):79-86. PubMed ID: 2991150
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
    Galante D, Esposito S, Barba D, Ruffilli MP.
    J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Clindamycin versus ampicillin in the treatment of odontogenic infections.
    Mangundjaja S, Hardjawinata K.
    Clin Ther; 1990 Apr; 12(3):242-9. PubMed ID: 2379229
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Unasyn in severe hospital infections].
    Sechser T, Hatala M, Svácek J, Modr Z.
    Cas Lek Cesk; 1991 May 24; 130(14):438-44. PubMed ID: 2070390
    [Abstract] [Full Text] [Related]

  • 60. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. The need for gram-negative coverage.
    Weber RS, Raad I, Frankenthaler R, Hankins P, Byers RM, Guillamondegui O, Wolf P, Smith T, Goepfert H.
    Arch Otolaryngol Head Neck Surg; 1992 Nov 24; 118(11):1159-63. PubMed ID: 1418893
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.